Corpus Intelligence IC Memo — ROANE COUNTY MEDICAL CENTER 2026-04-26 11:18 UTC
IC Memo — ROANE COUNTY MEDICAL CENTER
Investment Committee Memorandum | TN | 52 beds | Grade D | EBITDA uplift $3.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ROANE COUNTY MEDICAL CENTER

CCN 440031 | ROANE, TN | 52 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ROANE COUNTY MEDICAL CENTER is a 52-bed community hospital in ROANE, TN with $44.3M in net patient revenue and a 2.4% operating margin. The hospital serves a payer mix of 24.9% Medicare, 0.0% Medicaid, and 75.1% commercial.

Thesis: Turnaround. Our ML models identify $3.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.4% to 9.8% (+736bps).

Net Revenue HCRIS$44.3M
Current EBITDA COMPUTED$1.1M
Operating Margin COMPUTED2.4%
Occupancy HCRIS60.0%
Revenue / Bed COMPUTED$852K
Net-to-Gross HCRIS30.0%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
59
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 2.4% places it above the state median. Among 59 size-comparable peers (26-104 beds), the median margin is 0.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (26-104), prioritizing same-state peers. 59 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ROANE COUNTY MEDICAL CENTER (Target)TN52$44.3M2.4%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
SOUTHERN HILLS MEDICAL CENTERTN101$145.2M16.4%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
HORIZON MEDICAL CENTERTN96$141.3M15.3%
MORRISTOWN-HAMBLEN HOSPITALTN102$126.6M11.8%
LECONTE MEDICAL CENTERTN60$126.3M6.4%
FRANKLIN WOODS COMMUNITY HOSPITN80$110.3M18.7%
GREENEVILLE COMMUNITY HOSPITALTN81$104.5M-5.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$930K+210bp18mo
Cost to Collect4.5%2.5%$886K+200bp12mo
Denial Rate Reduction12.0%6.5%$877K+198bp12mo
A/R Days Reduction5200.0%3800.0%$539K+122bp9mo
Clean Claim Rate88.0%96.0%$28K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$930K
Cost to Collect
$886K
Denial Rate Reduction
$877K
A/R Days Reduction
$539K
Clean Claim Rate
$28K
Total EBITDA Uplift$3.3M
Current EBITDA$1.1M
+ RCM Uplift+$3.3M
Pro Forma EBITDA$4.3M
Current Margin2.4%
Pro Forma Margin9.8%
WC Released (1x)$1.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.6M$39.6M24.15x89.1%
Base (11x exit)10.0x11.0x$1.6M$44.1M26.89x93.2%
Bull Case9.0x11.0x$1.5M$55.4M37.52x106.5%
Bull (12x exit)9.0x12.0x$1.5M$60.9M41.23x110.4%
Bear Case11.0x10.0x$1.8M$22.8M12.63x66.1%
Bear (11x exit)11.0x11.0x$1.8M$25.7M14.22x70.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 59 hospitals with 26-104 beds
  • Same-state prioritization (n=60)
  • Comp margins: P25=-11.3% / P50=0.0% / P75=12.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.